TY - JOUR
T1 - β2-Adrenergic receptor agonist induces IL-18 production without IL-12 production
AU - Takahashi, Hideo K.
AU - Iwagaki, Hiromi
AU - Mori, Shuji
AU - Yoshino, Tadashi
AU - Tanaka, Noriaki
AU - Nishibori, Masahiro
N1 - Funding Information:
This study was supported in part by a grant for Promotion of Research from Okayama University (No. 21 to MN), a grant from Okayama Medical Foundation (to HKT) and grants from Grant-in-Aid for Scientific Resarch (C) (15590467 to HKT and 15590228 to MN). The authors thank Ms. Yumiko Shiotani and Ms. Yuki Onoda for the excellent technical assistance.
PY - 2004/6
Y1 - 2004/6
N2 - Endogenous catecholamine, epinephrine and norepinephrine, and isoproterenol concentration-dependently induced the production of interleukin (IL)-18, tumor necrosis factor (TNF)-α and interferon (IFN)-γ, and inhibited that of IL-10 in human peripheral blood mononuclear cells (PBMC). All responses by these stimulations were antagonized by the selective β2-adrenergic receptor (AR) antagonist, butoxamine, but not by α1-, α2- and β1-AR antagonists. The selective β2-AR agonists, salbutamol and terbutaline, induced a similar pattern of cytokine production, indicating that the effect of these AR agonists on cytokine production was through β2-AR stimulation. Anti-IL-18 Ab or caspase-1 inhibitor prevented all increase/decrease effects, suggesting that IL-18 might affect the production of all other cytokines. While endogenous IL-18 produced by salbutamol and terbutaline reached a sufficient concentration to induce IL-12 production, these β2-AR agonists did not induce the production of IL-12 at all. Epinephrine/norepinephrine/isoproterenol/ β2-AR agonists increased the production of IL-18 in monocytes, but had no effect on IL-12, TNF-α, IFN-γ and IL-10 production. The lack of β2-AR-induced effect on IL-12 production was due to a β2-AR-induced inhibition of an IL-18-elicited upregulation of both CD40 and CD40 ligand (CD40L/CD154) expressions on monocytes. The sympathetic innervating lymphoid organs may be under the control of β2-AR stimulation, maintaining the basal cytokine environment in the tissues.
AB - Endogenous catecholamine, epinephrine and norepinephrine, and isoproterenol concentration-dependently induced the production of interleukin (IL)-18, tumor necrosis factor (TNF)-α and interferon (IFN)-γ, and inhibited that of IL-10 in human peripheral blood mononuclear cells (PBMC). All responses by these stimulations were antagonized by the selective β2-adrenergic receptor (AR) antagonist, butoxamine, but not by α1-, α2- and β1-AR antagonists. The selective β2-AR agonists, salbutamol and terbutaline, induced a similar pattern of cytokine production, indicating that the effect of these AR agonists on cytokine production was through β2-AR stimulation. Anti-IL-18 Ab or caspase-1 inhibitor prevented all increase/decrease effects, suggesting that IL-18 might affect the production of all other cytokines. While endogenous IL-18 produced by salbutamol and terbutaline reached a sufficient concentration to induce IL-12 production, these β2-AR agonists did not induce the production of IL-12 at all. Epinephrine/norepinephrine/isoproterenol/ β2-AR agonists increased the production of IL-18 in monocytes, but had no effect on IL-12, TNF-α, IFN-γ and IL-10 production. The lack of β2-AR-induced effect on IL-12 production was due to a β2-AR-induced inhibition of an IL-18-elicited upregulation of both CD40 and CD40 ligand (CD40L/CD154) expressions on monocytes. The sympathetic innervating lymphoid organs may be under the control of β2-AR stimulation, maintaining the basal cytokine environment in the tissues.
KW - Adhesion molecules
KW - Cytokines
KW - Human
KW - Monocytes/macrophages
UR - http://www.scopus.com/inward/record.url?scp=2442493019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442493019&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2004.03.001
DO - 10.1016/j.jneuroim.2004.03.001
M3 - Article
C2 - 15145612
AN - SCOPUS:2442493019
SN - 0165-5728
VL - 151
SP - 137
EP - 147
JO - Advances in Neuroimmunology
JF - Advances in Neuroimmunology
IS - 1-2
ER -